Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pirbright receives funding for avian flu research
One of the most recent avian flu strains to transmit from birds to humans was H7N9
Scientists to assess how fast bird flu can adapt to infect humans

The Pirbright Institute has received funding to research how fast avian influenza can adapt to infect mammalian hosts. It is hoped that the research will help scientists identify which strains may pose a threat to humans and potentially cause the next pandemic.

Lead researcher Dr Holly Shelton, said: “Understanding more about how flu viruses change in hosts will help us to know what genetic characteristics to look out for when predicting the next strains that could cause human pandemics.

“We want to know how quickly mutations can appear that allow H9N2 to infect mammals if other strains have the potential to adapt at the same rate, and what features help them to adapt to mammals so rapidly.”

In recent years, the speed at which avian flu viruses can infect humans has become of great concern. One of the most recent avian flu strains to transmit from birds to humans was H7N9, which has infected more than 1500 people since 2013 and has a 40 per cent mortality rate.

Whilst there is not yet any evidence to suggest that H7N9 is able to transmit human-to-human, there is no way to tell if it will do so in the future.

Previous research by the Influenza Viruses group at Pirbright revealed that avian flu strain H9N2 is able to quickly adapt the viral genes involved in replication during infection of mice.

Since the H9N2 strain is known to have donated genetic material to the H7N9 virus, it may have transmitted crucial traits that improve its ability to infect humans. The scientists are therefore looking at the H9N2 genes to see what features they give the virus which enable it to rapidly adapt to a non-avian host.

Researchers say their study will aid decisions about flu eradication and control strategies in the avian population, which in turn will prevent spill-over public health events.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.